Hologic, Inc. (LON: 0J5Q)
London
· Delayed Price · Currency is GBP · Price in USD
72.34
+0.46 (0.64%)
At close: Jan 31, 2025
Hologic Revenue
In the fiscal year ending September 28, 2024, Hologic had annual revenue of $4.03B USD, down -0.00%. Hologic had revenue of $988.00M in the quarter ending September 28, 2024, with 4.52% growth.
Revenue
$4.03B
Revenue Growth
-0.00%
P/S Ratio
n/a
Revenue / Employee
$570.62K
Employees
7,063
Market Cap
13.10B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 28, 2024 | 4.03B | -100.00K | -0.00% |
Sep 30, 2023 | 4.03B | -832.40M | -17.12% |
Sep 24, 2022 | 4.86B | -769.50M | -13.66% |
Sep 25, 2021 | 5.63B | 1.86B | 49.14% |
Sep 26, 2020 | 3.78B | 409.10M | 12.15% |
Sep 28, 2019 | Pro | Pro | Pro |
Sep 29, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 24, 2016 | Pro | Pro | Pro |
Sep 26, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
Hikma Pharmaceuticals | 2.39B |
ConvaTec Group | 1.74B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
Hologic News
- 10 days ago - How Is The Market Feeling About Hologic? - Benzinga
- 12 days ago - Hologic Inc (HOLX) Reports Decline in Global Women's Cancer Testing - GuruFocus
- 12 days ago - New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide - Financial Post
- 12 days ago - New Report Reveals Alarming Decline in Women's Cancer Testing Worldwide - Business Wire
- 15 days ago - FDA Warns Hologic Over BioZorb Manufacturing Violations - Benzinga
- 16 days ago - Hologic: Reasonably, But Not Compellingly Valued - Seeking Alpha
- 20 days ago - Hologic says Q1 EPS expected to be near high end of guidance ranges - Seeking Alpha
- 20 days ago - Hologic Inc (HOLX) Announces Preliminary Q1 2025 Revenue Results - GuruFocus